99mtc-mibi and tl spet in the detection of recurrent brain tumours after radiation therapy

Nuclear Medicine Communications

Volumn 23, Issue 12, 2002, Pages 1183-1190

  Yamamoto, Y ^a   Nishiyama, Y ^a   Toyama, Y ^a   Kunishio, K ^a   Satoh, K ^a   Ohkawa, M ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

99mTc MIBI; Brain tumour; Radiation necrosis; Recurrent tumour; Tl

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM 201;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; NECROSIS; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TUMOR RECURRENCE; BRAIN TISSUE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOLOGY; IMAGING; PHOTON EMISSION TOMOGRAPHY; RADIATION NECROSIS;

ADULT; AGED; BRAIN NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036915178     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200212000-00006     Document Type: Article

References (41)

1. Dooms GC, Hecht S, Brant-Zawadzki M, et al. Brain radiation lesions: MR imaging. Radiology 1986; 158: 149-155.
2. Lilja A, Spannare B, Olson Y. Reliability of CT in assessing histopathological features of malignant supratentorial gliomas. J Comput Assist Tomogr 1984; 5: 625-634.
3. Rizzoli HV, Pagnanelli DM. Treatment of delayed radiation necrosis of the brain. A clinical observation. J Neurosurg 1984; 60: 589-594.
4. Jinnouchi S, Hoshi H, Ohnishi T, et al. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 1993; 34: 2091-2094.
5. Taki S, Kakuda K, Kakuma K, et al. Tl-201 SPET in the differential diagnosis of brain tumours. Nucl Med Commun 1999; 20: 637-645.
6. Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
7. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, De Deyn PP. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21: 621-633.
8. Buckard R, Kaiser KP, Wieler H, et al. Contribution of thallium-201 to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15: 265-273.
9. Ishibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36: 2201-206.
10. Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 1998; 25: 1261-1269.
11. Sun D, Liu Q, Liu W, Hu W. Clinical application of Tl-201 SPECT imaging of brain tumors. J Nucl Med 2000; 41: 5-10.
12. Kosuda S, Fujii H, Aoki S, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993; 7: 257-263.
13. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of Tl-201 SPECT vs F-18 fluorodeoxyglucose PET. Am J Roentgenol 1994; 163: 1459-1465.
14. Buchpiguel CA, Alavi JB, Alavi A, Kenyon LC. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 1995; 36: 159-164.
15. Nishiyama Y, Kawasaki Y, Yamamoto Y, et al. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer. J Nucl Med 1997; 38: 1358-1361.
16. O'Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 1990; 31: 2040-2041.
17. O'Tuama LA, Treves ST, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
18. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 1061-1066.
19. Yokogami K, Kawano H, Moriyama T, et al. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of Tc-99m sestamibi SPET? Eur J Nucl Med 1998; 25: 401-409.
20. 201Tl chloride SPET in patients with malignant brain tumours. Nucl Med Commun 2001; 22: 631-639.
21. Maffioli L, Gasparini M, Chiti A, et al. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 1996; 23: 308-311.
22. Soler C, Beauchesne P, Maatougui K, et al. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25: 1649-1657.
23. Yamamoto Y, Kusuhara T, Kumazawa Y, et al. The effect of scattering in simultaneous acquisitions of Tc-99m and Tl-201 - A fundamental study through phantom experiments. Radioisotopes 1996; 45: 369-374.
24. Caveness WF. Pathology of radiation damage to the normal brain of the monkey. Natl Cancer Inst Monogr 1977; 46: 57-76.
25. Yoshii Y, Phillips TL. Late vascular effects of whole brain X-irradiation in the mouse. Acta Neurochir 1982; 64: 87-102.
26. Valk PE, Dillon WP. Radiation injury of the brain. Am J Neuroradiol 1991; 12: 45-62.
27. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000; 21: 901-909.
28. Yoshii Y, Satou M, Yamamoto T, et al. The role of thallium-201 single-photon emission tomography in the investigation and characterization of brain tumours in man and their response to treatment. Eur J Nucl Med 1993; 20: 39-45.
29. Kline JL, Noto RB, Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. Am J Neuroradiol 1996; 17: 1681-1686.
30. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potential on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse. J Nucl Med 1990; 31: 1646-1653.
31. Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I. Technetium-99m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995; 16: 253-257.
32. Sasaki M, Ichiya Y, Kuwabara Y, et al. Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity. J Nucl Med 1996; 37: 1174-1176.
33. De Vries B, Taphoorn MJB, van Isselt JW, Terhaard CHJ, Jansen GH, Elsenburg PHJM. Bilateral temporal lobe necrosis after radiotherapy: confounding SPECT results. Neurology 1998; 51: 1183-1184.
34. Yoshii Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M. Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. Am J Neuroradiol 1996; 17: 1773-1776.
35. Groothius DR, Wright DC, Ostertag CB. The effect of I-125 interstitial radiotherapy on blood brain barrier function in normal canine brain. J Neurosurg 1987; 67: 895-902.
36. Kosarov LB, Friedman H. Enhanced Na+-K+-activated adenosine triphosphatase activity in transforming fibroblast. Cancer Res 1974; 34: 1862-1865.
37. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. Am J Roentgenol 1988; 150: 189-197.
38. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000; 41: 1861-1867.
39. Ogawa T, Kanno I, Shishido F, et al. Clinical value of PET with F-18-fluorodeoxyglucose and L-methyl-C-11-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202.
40. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
41. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine. J Nucl Med 1998; 39: 23-27.